UltiMaker to support Bioactivx in scale-up of 3D printing-enabled synthetic skin substitute
UltiMaker has signed a Memorandum of Understanding (MOU) with Singapore-based MedTech startup Bioactivx to co-develop a scalable, on-demand medical printing solution for regenerative wound care. The partnership follows the opening of Bioactivx's medical-grade filament production and cleanroom print farm facility and its obtainment of HSA approval for its flagship Bioactiv Matrix product. Bioactiv Matrix is a 3D…
摘要说明：本条资讯由 AMNews 增材制造新闻 从 TCT Magazine 自动聚合。原文版权归原出版方所有。
前往 TCT Magazine 阅读全文 →